nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP1A1—liver cancer	0.852	1	CbGaD
Mebendazole—ABCB1—Sorafenib—liver cancer	0.0132	0.389	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—liver cancer	0.00804	0.236	CbGbCtD
Mebendazole—CYP3A4—Sorafenib—liver cancer	0.00794	0.233	CbGbCtD
Mebendazole—CYP3A4—Doxorubicin—liver cancer	0.00482	0.141	CbGbCtD
Mebendazole—Albendazole—CYP1A1—liver cancer	0.00283	0.899	CrCbGaD
Mebendazole—Ketoprofen—ALB—liver cancer	0.000319	0.101	CrCbGaD
Mebendazole—TUBB4B—Cell Cycle—PSMA4—liver cancer	0.000184	0.00166	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000184	0.00166	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000183	0.00165	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000183	0.00165	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—ATF3—liver cancer	0.000182	0.00164	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000182	0.00164	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000178	0.00161	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000173	0.00156	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000164	0.00148	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP2E1—liver cancer	0.000161	0.00145	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000159	0.00143	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000158	0.00142	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000156	0.0014	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARA—liver cancer	0.000151	0.00136	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000149	0.00135	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—liver cancer	0.000148	0.00134	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000148	0.00133	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GGT1—liver cancer	0.000148	0.00133	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000146	0.00131	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000145	0.00131	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—CYCS—liver cancer	0.000145	0.0013	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000143	0.00129	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000143	0.00129	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.000143	0.00129	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000143	0.00129	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000142	0.00128	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000141	0.00127	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000139	0.00126	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—F2—liver cancer	0.000137	0.00123	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000135	0.00122	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000133	0.0012	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000133	0.0012	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTP1—liver cancer	0.000133	0.0012	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000132	0.00119	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000132	0.00119	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTP1—liver cancer	0.000131	0.00118	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000131	0.00118	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000131	0.00118	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PCNA—liver cancer	0.00013	0.00118	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000129	0.00116	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—liver cancer	0.000128	0.00115	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000128	0.00115	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000126	0.00114	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000126	0.00113	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—liver cancer	0.000125	0.00113	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—H2AFX—liver cancer	0.000124	0.00112	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000123	0.00111	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—liver cancer	0.000122	0.0011	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTM1—liver cancer	0.000122	0.0011	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000122	0.0011	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—liver cancer	0.000121	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTM1—liver cancer	0.00012	0.00109	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00012	0.00108	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000118	0.00106	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000117	0.00105	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PCNA—liver cancer	0.000117	0.00105	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP2—liver cancer	0.000116	0.00105	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000114	0.00102	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1B—liver cancer	0.000113	0.00102	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF2—liver cancer	0.000113	0.00102	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—liver cancer	0.000113	0.00102	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000113	0.00101	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000109	0.000981	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—liver cancer	0.000108	0.000972	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000107	0.000967	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000107	0.000962	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1A—liver cancer	0.000104	0.00094	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	0.000102	0.000921	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000102	0.00092	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—PPARA—liver cancer	0.000102	0.000916	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	9.97e-05	0.000899	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—HPGDS—liver cancer	9.73e-05	0.000877	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—liver cancer	9.67e-05	0.000872	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	9.54e-05	0.00086	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	9.51e-05	0.000858	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—liver cancer	9.51e-05	0.000858	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—liver cancer	9.5e-05	0.000856	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	9.32e-05	0.00084	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	9.12e-05	0.000822	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	9.12e-05	0.000822	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTNNB1—liver cancer	8.9e-05	0.000802	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	8.68e-05	0.000783	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UGDH—liver cancer	8.66e-05	0.000781	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—liver cancer	8.64e-05	0.000779	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	8.63e-05	0.000778	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—liver cancer	8.61e-05	0.000777	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	8.44e-05	0.000761	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—F2—liver cancer	8.26e-05	0.000745	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	8.18e-05	0.000738	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EPT1—liver cancer	8.14e-05	0.000734	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—liver cancer	8.07e-05	0.000728	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2E1—liver cancer	7.93e-05	0.000715	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	7.82e-05	0.000705	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TAT—liver cancer	7.72e-05	0.000696	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—liver cancer	7.7e-05	0.000694	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—liver cancer	7.63e-05	0.000688	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	7.59e-05	0.000684	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—liver cancer	7.55e-05	0.000681	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TGFB1—liver cancer	7.41e-05	0.000668	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GGT1—liver cancer	7.28e-05	0.000656	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—liver cancer	7.28e-05	0.000656	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	7.18e-05	0.000648	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—liver cancer	7.1e-05	0.00064	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	7.05e-05	0.000635	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—liver cancer	7.04e-05	0.000635	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP2—liver cancer	7.01e-05	0.000632	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—liver cancer	6.92e-05	0.000624	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UGDH—liver cancer	6.92e-05	0.000623	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—RAF1—liver cancer	6.83e-05	0.000616	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1B—liver cancer	6.82e-05	0.000615	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	6.66e-05	0.0006	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—liver cancer	6.54e-05	0.00059	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—liver cancer	6.51e-05	0.000587	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EPT1—liver cancer	6.5e-05	0.000586	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	6.45e-05	0.000581	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1A—liver cancer	6.3e-05	0.000568	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TAT—liver cancer	6.16e-05	0.000556	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTM1—liver cancer	6.01e-05	0.000542	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.95e-05	0.000536	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.93e-05	0.000534	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—liver cancer	5.84e-05	0.000526	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.7e-05	0.000514	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.68e-05	0.000512	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.62e-05	0.000507	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTNNB1—liver cancer	5.37e-05	0.000484	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CPT1B—liver cancer	5.25e-05	0.000473	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GLUL—liver cancer	5.25e-05	0.000473	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	5.23e-05	0.000471	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—liver cancer	5.22e-05	0.000471	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NR1H4—liver cancer	5.06e-05	0.000456	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA3—liver cancer	4.97e-05	0.000448	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.79e-05	0.000432	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.69e-05	0.000423	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.57e-05	0.000412	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.56e-05	0.000411	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA4—liver cancer	4.55e-05	0.00041	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.52e-05	0.000408	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA2—liver cancer	4.43e-05	0.0004	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.42e-05	0.000398	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	4.4e-05	0.000396	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.31e-05	0.000389	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—liver cancer	4.29e-05	0.000387	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA1—liver cancer	4.28e-05	0.000386	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGDH—liver cancer	4.26e-05	0.000384	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAT2—liver cancer	4.23e-05	0.000381	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CPT1B—liver cancer	4.19e-05	0.000378	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GLUL—liver cancer	4.19e-05	0.000378	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.07e-05	0.000367	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALDOB—liver cancer	4.05e-05	0.000365	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NR1H4—liver cancer	4.04e-05	0.000364	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EPT1—liver cancer	4.01e-05	0.000361	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.98e-05	0.000359	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA3—liver cancer	3.97e-05	0.000358	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CRABP1—liver cancer	3.87e-05	0.000349	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.82e-05	0.000345	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TAT—liver cancer	3.8e-05	0.000342	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.66e-05	0.00033	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.66e-05	0.00033	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA4—liver cancer	3.63e-05	0.000328	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA2—liver cancer	3.54e-05	0.000319	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.48e-05	0.000314	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA1—liver cancer	3.42e-05	0.000308	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.41e-05	0.000308	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.39e-05	0.000305	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HPGDS—liver cancer	3.38e-05	0.000305	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAT2—liver cancer	3.38e-05	0.000304	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.36e-05	0.000303	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALDOB—liver cancer	3.24e-05	0.000292	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	3.11e-05	0.00028	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CRABP1—liver cancer	3.09e-05	0.000278	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	3.09e-05	0.000278	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.06e-05	0.000276	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.02e-05	0.000272	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSMA4—liver cancer	3.01e-05	0.000272	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PSMD10—liver cancer	3.01e-05	0.000272	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	3.01e-05	0.000271	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GOT2—liver cancer	2.93e-05	0.000264	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2E1—liver cancer	2.76e-05	0.000248	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HPGDS—liver cancer	2.7e-05	0.000243	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.67e-05	0.000241	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GLUL—liver cancer	2.58e-05	0.000233	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CPT1B—liver cancer	2.58e-05	0.000233	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYCS—liver cancer	2.58e-05	0.000232	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.54e-05	0.000229	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GGT1—liver cancer	2.53e-05	0.000228	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GOT1—liver cancer	2.53e-05	0.000228	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NR1H4—liver cancer	2.49e-05	0.000224	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA3—liver cancer	2.45e-05	0.000221	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSMA4—liver cancer	2.41e-05	0.000217	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PSMD10—liver cancer	2.41e-05	0.000217	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GOT2—liver cancer	2.34e-05	0.000211	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.29e-05	0.000207	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—liver cancer	2.27e-05	0.000205	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HMOX1—liver cancer	2.24e-05	0.000202	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA4—liver cancer	2.24e-05	0.000202	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2E1—liver cancer	2.2e-05	0.000198	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA2—liver cancer	2.18e-05	0.000197	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA1—liver cancer	2.1e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—liver cancer	2.09e-05	0.000188	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAT2—liver cancer	2.08e-05	0.000188	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.08e-05	0.000187	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYCS—liver cancer	2.06e-05	0.000186	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GGT1—liver cancer	2.02e-05	0.000182	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GOT1—liver cancer	2.02e-05	0.000182	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALDOB—liver cancer	1.99e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CRABP1—liver cancer	1.9e-05	0.000172	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—liver cancer	1.85e-05	0.000166	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—liver cancer	1.82e-05	0.000164	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARA—liver cancer	1.81e-05	0.000163	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HMOX1—liver cancer	1.79e-05	0.000161	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—liver cancer	1.67e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HPGDS—liver cancer	1.66e-05	0.00015	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.63e-05	0.000147	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A1—liver cancer	1.58e-05	0.000143	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—liver cancer	1.55e-05	0.00014	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—liver cancer	1.5e-05	0.000135	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSMA4—liver cancer	1.48e-05	0.000134	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PSMD10—liver cancer	1.48e-05	0.000134	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—liver cancer	1.47e-05	0.000133	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARA—liver cancer	1.45e-05	0.00013	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GOT2—liver cancer	1.44e-05	0.00013	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—liver cancer	1.36e-05	0.000123	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2E1—liver cancer	1.36e-05	0.000122	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—liver cancer	1.35e-05	0.000121	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYCS—liver cancer	1.27e-05	0.000114	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GGT1—liver cancer	1.24e-05	0.000112	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GOT1—liver cancer	1.24e-05	0.000112	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—liver cancer	1.24e-05	0.000112	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—liver cancer	1.2e-05	0.000108	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—liver cancer	1.19e-05	0.000107	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—liver cancer	1.12e-05	0.000101	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HMOX1—liver cancer	1.1e-05	9.94e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—liver cancer	1.09e-05	9.82e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—liver cancer	1.07e-05	9.69e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—liver cancer	1.03e-05	9.27e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A1—liver cancer	9.74e-06	8.78e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—liver cancer	9.49e-06	8.56e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—liver cancer	9.08e-06	8.19e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARA—liver cancer	8.91e-06	8.03e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—liver cancer	7.63e-06	6.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—liver cancer	7.36e-06	6.64e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—liver cancer	7.24e-06	6.53e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—liver cancer	6.71e-06	6.05e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—liver cancer	6.62e-06	5.97e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—liver cancer	5.92e-06	5.33e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—liver cancer	5.85e-06	5.27e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—liver cancer	5.79e-06	5.22e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—liver cancer	4.73e-06	4.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—liver cancer	3.56e-06	3.21e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—liver cancer	2.91e-06	2.63e-05	CbGpPWpGaD
